Promoting eye and skin health through intake of the natural carotenoid lutein

Wild-Type Food in Health Promotion and Disease Prevention: The Columbus Concept

Volumn , Issue , 2008, Pages 331-342

  Lewis, Brandon ^a  

^a Kemin Industries Inc   (United States)

Author keywords

eye health; Lutein; skin health; zeaxanthin

Indexed keywords

EID: 77951288220     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-330-1_23     Document Type: Chapter

References (61)

1. Khachik F, Beecher GR, Goli MB, Lusby WR, Smith JC, Jr. Separation and identification of carotenoids and their oxidation products in the extracts of human plasma. Anal Chem 1992;64(18): 2111-2122.
2. Krinsky NI, Russett MD, Handelman GJ, Snodderly DM. Structural and geometrical isomers of carotenoids in human plasma. J Nutr 1990;120(12):1654- 1662.
3. Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol 1997;17(4):786-796.
4. Sujak A, Gabrielska J, Grudzinski W, Borc R, Mazurek P, Gruszecki WI. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: The structural aspects. Arch Biochem Biophys 1999;371(2):301-307.
5. Sujak A, Okulski W, Gruszecki WI. Organisation of xanthophyll pigments lutein and zeaxanthin in lipid membranes formed with dipalmitoylphosphatidylcholine. Biochim Biophys Acta 2000;1509 (1-2):255-263.
6. Kuhlbrandt W, Wang DN, Fujiyoshi Y. Atomic model of plant light-harvesting complex by electron crystallography. Nature 1994;367(6464):614-621.
7. Khachik F, Bernstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 1997;38(9):1802-1811.
8. van Vliet T. Absorption of beta-carotene and other carotenoids in humans and animal models. Eur J Clin Nutr 1996;50 Suppl 3:S32-S37.
9. Parker RS. Absorption, metabolism, and transport of carotenoids. FASEB 1996;10(5):542-551.
10. Peng YM, Peng YS, Lin Y. A nonsaponification method for the determination of carotenoids, retinoids, and tocopherols in solid human tissues. Cancer Epidemiol Biomarkers Prev 1993;2(2):139-144.
11. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 2001;385(1):28-40.
12. Craft NE, Haitema TB, Garnett KM, Fitch KA, Dorey CK. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging 2004;8(3):156-162.
13. Yeum KJ, Ahn SH, Rupp de Paiva SA, Lee-Kim YC, Krinsky NI, Russell RM. Correlation between carotenoid concentrations in serum and normal breast adipose tissue of women with benign breast tumor or breast cancer. J Nutr 1998;128(11):1920-1926.
14. Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao DY, Katz NB. Identification and Quantitation of Carotenoids and their Metabolites in the Tissues of the Human Eye. Exp Eye Res 2001;72(3):215-223.
15. Castenmiller JJ, West CE, Linssen JP, van het Hof KH, Voragen AG. The food matrix of spinach is a limiting factor in determining the bioavailability of beta-carotene and to a lesser extent of lutein in humans. J Nutr 1999;129(2):349-355.
16. van het Hof KH, Brouwer IA, West CE, et al. Bioavailability of lutein from vegetables is 5 times higher than that of beta-carotene. Am J Clin Nutr 1999;70(2):261-268.
17. Handelman GJ, Nightingale ZD, Lichtenstein AH, Schaefer EJ, Blumberg JB. Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk. Am J Clin Nutr 1999; 70(2):247-251.
18. Chung HY, Rasmussen HM, Johnson EJ. Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men. J Nutr Aug 2004;134(8):1887-1893.
19. Brown L, Rimm EB, Seddon JM, et al. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr 1999;70(4):517-524.
20. Chasan-Taber L, Willett WC, Seddon JM, et al. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nutr 1999;70(4):509-516.
21. Gonzalez S, Astner S, An W, Goukassian D, Pathak MA. Dietary lutein/zeaxanthin decreases ultraviolet B-induced epidermal hyperproliferation and acute inflammation in hairless mice. J Invest Dermatol. Aug 2003;121(2):399-405.
22. Lee EH, Faulhaber D, Hanson KM, et al. Dietary lutein reduces ultraviolet radiation-induced inflammation and immunosuppression. J Invest Dermatol. Feb 2004;122(2):510-517.
23. Millen AE, Tucker MA, Hartge P, et al. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev Jun 2004;13(6):1042-1051.
24. Morganti P, Bruno C, Guarneri F, Cardillo A, Del Ciotto P, Valenzano F. Role of topical and nutritional supplement to modify the oxidative stress. Int J Cosmetic Science 2002;24:331-339.
25. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: The Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004;75(4):216-230.
26. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003;23:171-201.
27. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: Retinal distribution and age study. Invest Ophthalmol Vis Sci 1988;29(6):843-849.
28. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 1993;34(6):2033-2040.
29. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional Manipulation of Primate Retinas, III: Effects of Lutein or Zeaxanthin Supplementation on Adipose Tissue and Retina of Xanthophyll-Free Monkeys. Invest Ophthalmol Vis Sci 2005;46(2):692-702.
30. Wooten BR, Hammond BR. Macular pigment: Influences on visual acuity and visibility. Prog Retin Eye Re. 2002;21(2):225-240.
31. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol Apr 2004;122(4):564-572.
32. Brown B, Adams AJ, Coletta NJ, Haegerstrom-Portnoy G. Dark adaptation in age-related maculopathy. Ophthalmic Physiol Opt 1986;6(1):81-84.
33. Kleiner RC, Enger C, Alexander MF, Fine SL. Contrast sensitivity in age-related macular degeneration. Arch Ophthalmol 1988;106(1):55-57.
34. Midena E, Segato T, Blarzino MC, Degli Angeli C. Macular drusen and the sensitivity of the central visual field. Doc Ophthalmol 1994;88(2):179-185.
35. Midena E, Degli Angeli C, Blarzino MC, Valenti M, Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci Feb 1997;38(2):469-477.
36. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmolog. 1997;104(1):7-21.
37. Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group. Arch Ophthalmol 1993;111(1):104-109.
38. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994;272(18): 1413-1420.
39. Curran-Celentano J, Hammond BR, Jr., Ciulla TA, Cooper DA, Pratt LM, Danis RB. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 2001;74(6):796-802.
40. Broekmans WM, Berendschot TT, Klopping-Ketelaars IA, et al. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr 2002;76(3):595-603.
41. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: A case-control study. Invest Ophthalmol Vis Sci 2001;42(1):235-240.
42. Aleman TS, Duncan JL, Bieber ML, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and usher syndrome. Invest Ophthalmol Vis Sci 2001;42(8):1873-1881.
43. Duncan JL, Aleman TS, Gardner LM, et al. Macular pigment and lutein supplementation in choroideremia. Exp Eye Res 2002;74(3):371-381.
44. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 2000;41(11):3322-3326.
45. Hammond BR, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997;38(9):1795-1801.
46. Johnson EJ, Hammond BR, Yeum KJ, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 2000;71(6):1555-1562.
47. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one year study of the macular pigment: The effect of 140 days of a lutein supplement. Exp Eye Res 1997;65(1):57-62.
48. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age- related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119(10):1417-1436.
49. Richer S. ARMD-pilot (case series) environmental intervention data. J Am Optom Assoc 1999;70(1):24-36.
50. Chitchumroonchokchai C, Bomser JA, Glamm JE, Failla ML. Xanthophylls and -Tocopherol Decrease UVB-Induced Lipid Peroxidation and Stress Signaling in Human Lens Epithelial Cells. J Nutr Dec 2004;134(12):3225-3232.
51. Lyle BJ, Mares-Perlman JA, Klein BE, Klein R, Greger JL. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J Epidemiol 1999;149(9):801-809.
52. Gale CR, Hall NF, Phillips DI, Martyn CN. Plasma antioxidant vitamins and carotenoids and agerelated cataract. Ophthalmology 2001;108(11):1992-1998.
53. Olmedilla B, Granado F, Blanco I, Vaquero M. Lutein, but not alpha-Tocopherol, supplementation improves visual function in patients with age-related cataracts: A 2-y double-blind, placebo-controlled pilot study. Nutrition 2003;19(1):21-24.
54. Lange BA, Buettner GR. Electron paramagnetic resonance detection of free radicals in UV- irradiated human and mouse skin. Curr Probl Dermatol 2001;29:18-25.
55. O'Connor I, O'Brien N. Modulation of UVA light-induced oxidative stress by beta-carotene, lutein and astaxanthin in cultured fibroblasts. J Dermatol Sci 1998;16(3):226-230.
56. Wingerath T, Sies H, Stahl W. Xanthophyll esters in human skin. Arch Biochem Biophys 1998;355(2):271-274.
57. Greenway HT, Pratt S. Skin tissue levels of carotenoids, vitamin A, and antioxidants in photodamaged skin. La Jolla, Ca, Mohs Surgery Unit, Division of Dermatology and Cutaneous Surgury, Scripps Clinic, 1999.
58. Peng YM, Peng YS, Lin Y, Moon T, Roe DJ, Ritenbaugh C. Concentrations and plasma-Tissue-diet relationships of carotenoids, retinoids, and tocopherols in humans. Nutr Cancer 1995;23(3):233-246.
59. Millen AE. Diet and risk of malignant melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 2003 2003;12(11 Part 2):1339s.
60. Taylor EJ, Evans FJ. Anti-psoriatic action of lutein demonstrated by inhibition of rat photodermatitis. J Pharm Pharmacol 1998;50(Supplement):78.
61. Morganti P, Fabrizi G, Bruno C. Protective effects of oral antioxidants on skin and eye function. Skinmed 2004;3(6):310-316.